Dexmedetomidine Infusion During Laparoscopic Adrenalectomy

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 3, 2012

Primary Completion Date

March 26, 2021

Study Completion Date

March 26, 2021

Conditions
Pheochromocytoma
Interventions
DRUG

dexmedetomidine

In the dexmedetomidine group, dexmedetomidine is administered at a rate of 0.5 μg/kg/h immediately after anesthesia induction and continued until the completion of the surgery. The research nurse, who did not participate in the study other than the management and preparation of the study medication, prepared 50mL of 0.9% normal saline for the control group and a mixture of dexmedetomidine 2 mL and 0.9% normal saline 48 mL (at a concentration of 4 μg/mL) for the dexmedetomidine group.

DRUG

0.9% normal saline

In the control group, a 0.9% normal saline infusion is initiated at the same rate immediately after anesthesia induction and continued until the end of the operation.

Trial Locations (1)

Unknown

Severance hospital, Seoul

All Listed Sponsors
lead

Yonsei University

OTHER

NCT06037135 - Dexmedetomidine Infusion During Laparoscopic Adrenalectomy | Biotech Hunter | Biotech Hunter